Agile Therapeutics Inc
AGRXDelisted Jun 3, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001261249
Agile Therapeutics Inc was delisted on Jun 3, 2024; its insiders filed their last Form 4 on Aug 26, 2024; 21 institutions reported holding it in 13F filings for Q4 2023, worth $496.2K in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Agile Therapeutics Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −18 vs. Q1 2022
- Shares held
- 1.10M
- +86.1K (+8.5%) vs. Q1 2022Converted for a 1-for-40 split
- Total value
- $1.28M
- −$2.76M (−68.3%) vs. Q1 2022
- New holders
- 4
- 8 more added
- Sold out
- 22
- 5 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AGRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $596 |
| Q4 2023 | 21 | $496.2K |
| Q3 2023 | 17 | $355.2K |
| Q2 2023 | 16 | $425.8K |
| Q1 2023 | 23 | $337.2K |
| Q4 2022 | 27 | $371.5K |
| Q3 2022 | 28 | $683.0K |
| Q2 2022 | 21 | $1.28M |
| Q1 2022 | 39 | $4.04M |
| Q4 2021 | 47 | $18.4M |
| Q3 2021 | 54 | $30.5M |
| Q2 2021 | 71 | $45.7M |
| Q1 2021 | 78 | $79.6M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Agile Therapeutics Inc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 532,361 | $620.0K | 0.02% | 00.0% | UnchangedConverted for a 1-for-40 split |
| Renaissance Technologies LLC | 122,455 | $143.0K | 0.00% | +106,925+688.5% | AddedConverted for a 1-for-40 split |
| Jane Street Group, LLC | 92,347 | $108.0K | 0.00% | +92,347 | New |
| Investor AB | 87,754 | $103.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-40 split |
| Citigroup Inc | 58,572 | $68.0K | 0.00% | +57,983+9,835.9% | AddedConverted for a 1-for-40 split |
| BlackRock Inc. | 47,572 | $56.0K | 0.00% | +9,478+24.9% | AddedConverted for a 1-for-40 split |
| Two Sigma Investments, LP | 45,421 | $53.0K | 0.00% | +45,421 | New |
| Vanguard Group Inc | 30,113 | $35.0K | 0.00% | −66,821−68.9% | ReducedConverted for a 1-for-40 split |
| UBS Group AG | 25,513 | $30.0K | 0.00% | +24,112+1,721.3% | AddedConverted for a 1-for-40 split |
| Susquehanna International Group, LLP | 18,559 | $22.0K | 0.00% | +16,849+985.1% | AddedConverted for a 1-for-40 split |
| Millennium Management LLC | 16,947 | $20.0K | 0.00% | −4,081−19.4% | ReducedConverted for a 1-for-40 split |
| Geode Capital Management, LLC | 18,001 | $20.0K | 0.00% | −946−5.0% | ReducedConverted for a 1-for-40 split |
| Morgan Stanley | 2,014 | $2.00K | 0.00% | +719+55.5% | AddedConverted for a 1-for-40 split |
| Advisor Group Holdings, Inc. | 1,147 | $1.00K | 0.00% | −677−37.1% | ReducedConverted for a 1-for-40 split |
| Group One Trading, L.P. | 1,033 | $1.00K | 0.00% | 00.0% | UnchangedConverted for a 1-for-40 split |
| CWM, LLC | 125 | $0 | 0.00% | 00.0% | UnchangedConverted for a 1-for-40 split |
| JPMorgan Chase & Co | 166 | $0 | 0.00% | +163+5,936.4% | AddedConverted for a 1-for-40 split |
| Wells Fargo & Company | 151 | $0 | 0.00% | +86+131.9% | AddedConverted for a 1-for-40 split |
| Royal Bank of Canada | 7 | $0 | 0.00% | −43−85.9% | ReducedConverted for a 1-for-40 split |
| FMR LLC | 50 | $0 | 0.00% | +50 | New |
| Moisand Fitzgerald Tamayo, LLC | 2 | $0 | 0.00% | +2 | New |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −113,678−100.0% | Sold outConverted for a 1-for-40 split |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −54,933−100.0% | Sold outConverted for a 1-for-40 split |
| State Street Corp | 0 | $0 | 0.00% | −7,259−100.0% | Sold outConverted for a 1-for-40 split |
| First Citizens Bank & Trust Co | 0 | $0 | 0.00% | −5,000−100.0% | Sold outConverted for a 1-for-40 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −3,620−100.0% | Sold outConverted for a 1-for-40 split |
| Grimes & Company, Inc. | 0 | $0 | 0.00% | −2,795−100.0% | Sold outConverted for a 1-for-40 split |
| Parsec Financial Management, Inc. | 0 | $0 | 0.00% | −2,025−100.0% | Sold outConverted for a 1-for-40 split |
| Founders Capital Management | 0 | $0 | 0.00% | −500−100.0% | Sold outConverted for a 1-for-40 split |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −1,017−100.0% | Sold outConverted for a 1-for-40 split |
| HBK Sorce Advisory LLC | 0 | $0 | 0.00% | −875−100.0% | Sold outConverted for a 1-for-40 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −669−100.0% | Sold outConverted for a 1-for-40 split |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −500−100.0% | Sold outConverted for a 1-for-40 split |
| LPL Financial LLC | 0 | $0 | 0.00% | −506−100.0% | Sold outConverted for a 1-for-40 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −463−100.0% | Sold outConverted for a 1-for-40 split |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −492−100.0% | Sold outConverted for a 1-for-40 split |
| Kalos Management, Inc. | 0 | $0 | 0.00% | −419−100.0% | Sold outConverted for a 1-for-40 split |
| HRT Financial LP | 0 | $0 | 0.00% | −318−100.0% | Sold outConverted for a 1-for-40 split |
| Creative Planning | 0 | $0 | 0.00% | −255−100.0% | Sold outConverted for a 1-for-40 split |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −45−100.0% | Sold outConverted for a 1-for-40 split |
| Bank of America Corp | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-40 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −7−100.0% | Sold outConverted for a 1-for-40 split |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −53−100.0% | Sold outConverted for a 1-for-40 split |